更改

跳到导航 跳到搜索
删除5字节 、 2021年6月2日 (三) 07:52
第106行: 第106行:  
Although subjects almost always provide informed consent for their participation in an RCT, studies since 1982 have documented that RCT subjects may believe that they are certain to receive treatment that is best for them personally; that is, they do not understand the difference between research and treatment. Further research is necessary to determine the prevalence of and ways to address this "therapeutic misconception". For example, patients with terminal illness may join trials in the hope of being cured, even when treatments are unlikely to be successful.
 
Although subjects almost always provide informed consent for their participation in an RCT, studies since 1982 have documented that RCT subjects may believe that they are certain to receive treatment that is best for them personally; that is, they do not understand the difference between research and treatment. Further research is necessary to determine the prevalence of and ways to address this "therapeutic misconception". For example, patients with terminal illness may join trials in the hope of being cured, even when treatments are unlikely to be successful.
   −
尽管受试者几乎总是在知情的情况下同意参加随机对照试验,但自1982年以来的研究记录表明,随机对照试验的受试者可能认为他们肯定会接受对他们个人最好的治疗; 也就是说,他们不理解研究和治疗之间的区别。需要进一步研究,以确定这种”治疗性误解”的流行程度和解决方法。例如,患有晚期疾病的病人可能会加入临床试验,希望治愈,即使治疗不太可能成功。
+
一般来说,受试者要为参加随机对照试验提交了知情同意书,但1982年以来的研究记录表明,随机对照试验的受试者可能认为他们肯定会接受对他们个人最好的治疗; 也就是说,他们不理解研究和治疗之间的区别。需要进一步研究,以确定这种”治疗性误解”的流行程度和解决方法。例如,患有晚期疾病的病人可能会加入临床试验,希望治愈,即使治疗不太可能成功。
      第137行: 第137行:     
医学期刊在适应将强制性临床试验登记作为发表的先决条件的政策方面进展缓慢。
 
医学期刊在适应将强制性临床试验登记作为发表的先决条件的政策方面进展缓慢。
  −
      
== Classifications ==
 
== Classifications ==
21

个编辑

导航菜单